Volume 11, Issue 3 (2023)
Health Educ Health Promot 2023, 11(3): 513-517 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hameed A, Bakey S. Effectiveness of an Interventional Program on Nurses' Practices about Patients with Chemotherapy-Induced Peripheral Neuropathy. Health Educ Health Promot 2023; 11 (3) :513-517
URL: http://hehp.modares.ac.ir/article-5-56052-en.html
URL: http://hehp.modares.ac.ir/article-5-56052-en.html
A.T. Hameed *1, S.J. Bakey2
1- Department of Nursing, Nasiriya Technical Institute (NTI), Southern Technical University, Al_Nasiriyah, Iraq
2- Adult Nursing Department, College of Nursing, University of Baghdad, Baghdad, Iraq
2- Adult Nursing Department, College of Nursing, University of Baghdad, Baghdad, Iraq
Abstract: (463 Views)
Aims: To evaluate oncology nurses' practices regarding chemotherapy-induced peripheral neuropathy in cancer patients and whether there is a correlation between the effectiveness of an interventional program on nurses' practices and their demographics. This study aimed to evaluate the effectiveness of an interventional program on nurses' practices regarding patients with chemotherapy-induced peripheral neuropathy.
Materials & Methods: This quasi-experimental research was conducted with a pretest/posttest strategy, from October 28, 2021, to May 14, 2023, in Al-Habboubi Teaching Hospital. 60 nurses were selected by available sampling and were allocated into two groups; control and intervention (each 30 nurses). The data-gathering tool had two sections; demographic information of the nurses and an observation checklist for nurse practices regarding chemotherapy-induced peripheral neuropathy (27 items). The data was analyzed using SPSS 26 software by Chi-square and One-way analysis of variance.
Findings: There was no significant difference in practice scores regarding CIPN between the control (1.06±0.05) and study (1.03±0.04) groups (t=-2.658; p=0.13). The practice score of the study group (2.68±0.14) was significantly (t=-52.145; p<0.001) higher than that of the control group (1.11±0.07) after the intervention. One-way analysis of variance showed no relationships between the two groups in pretest and posttest according to demographic parameters.
Conclusion: The chemotherapy-induced peripheral neuropathy training program improves the practice of oncology nurses.
Materials & Methods: This quasi-experimental research was conducted with a pretest/posttest strategy, from October 28, 2021, to May 14, 2023, in Al-Habboubi Teaching Hospital. 60 nurses were selected by available sampling and were allocated into two groups; control and intervention (each 30 nurses). The data-gathering tool had two sections; demographic information of the nurses and an observation checklist for nurse practices regarding chemotherapy-induced peripheral neuropathy (27 items). The data was analyzed using SPSS 26 software by Chi-square and One-way analysis of variance.
Findings: There was no significant difference in practice scores regarding CIPN between the control (1.06±0.05) and study (1.03±0.04) groups (t=-2.658; p=0.13). The practice score of the study group (2.68±0.14) was significantly (t=-52.145; p<0.001) higher than that of the control group (1.11±0.07) after the intervention. One-way analysis of variance showed no relationships between the two groups in pretest and posttest according to demographic parameters.
Conclusion: The chemotherapy-induced peripheral neuropathy training program improves the practice of oncology nurses.
Keywords: Effectiveness, Program [MeSH], Practices [MeSH], Interventional Program [MeSH], Chemotherapy-Induced Peripheral Neuropathy [MeSH]
Article Type: Original Research |
Subject:
Health Education and Health Behavior
Received: 2023/04/23 | Accepted: 2023/07/16 | Published: 2023/08/5
Received: 2023/04/23 | Accepted: 2023/07/16 | Published: 2023/08/5
References
1. Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, et al. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther. 2021;9(2):385-450. [Link] [DOI:10.1007/s40487-021-00168-y]
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. [Link] [DOI:10.3322/caac.21551]
3. Nasser JA, Hassoun S. Effectiveness of health educational program on nurses' practices toward chemotherapy-induced peripheral neuropathy for children at hematology center in Baghdad City. Iraqi National Journal of Nursing Specialties. 2020;33(2):1-2. [Link] [DOI:10.58897/injns.v33i2.410]
4. Tofthagen CS, Visovsky C, Hopgood R. Chemotherapy-Induced Peripheral Neuropathy. Clin J Oncol Nsg. 2013;17(2):138-44. [Link] [DOI:10.1188/13.CJON.138-144]
5. Klafke N, Bossert J, Kroger B, Neuberger P, Heyder U, Layer M. Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process. Med Sci. 2023;11(1):15. [Link] [DOI:10.3390/medsci11010015]
6. Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451. [Link] [DOI:10.3390/ijms20061451]
7. Nasser JA, Hassoun S. Effectiveness of health educational program on nurses' practices toward chemotherapy-induced peripheral neuropathy for children at hematology center in Baghdad City. Iraqi Natl J Nurs Spec. 2020;33(2):1-2. [Link] [DOI:10.58897/injns.v33i2.410]
8. Atiyah HH. Assessment of factors that contribute to cancer of the larynx in Baghdad Teaching Hospitals. Al-Kufa Univ J Biol. 2018;24;10(3). [Link] [DOI:10.36320/ajb/v10.i3.8106]
9. Rocha Martin LG, Denis Pessoa Silva M. Chemotherapy-induced peripheral neuropathy: a literature review. Einstein. 2011;9(4):538-44. [Link] [DOI:10.1590/s1679-45082011rw2220]
10. Colvin LA. Chemotherapy-induced peripheral neuropathy (CIPN): where are we now?. Pain. 2019;160(1):S1-S10. [Link] [DOI:10.1097/j.pain.0000000000001540]
11. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461-70. [Link] [DOI:10.1016/j.pain.2014.09.020]
12. Starobova H, Irina V. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front Mol Neurosci. 2017;10:174. [Link] [DOI:10.3389/fnmol.2017.00174]
13. Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;119(4):737-49. [Link] [DOI:10.1093/bja/aex229]
14. Hershman DL, Lacchetti C, Dworkin RH, Smith EML, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941-67. [Link] [DOI:10.1200/JCO.2013.54.0914]
15. Al-Atiyyat N, Banifawaz AZ. Oncology nurses' knowledge, practice, and confidence toward chemotherapy-induced peripheral neuropathy in Jordan. Saudi Med J. 2018;39(11):1158-63. [Link] [DOI:10.15537/smj.2018.11.23303]
16. Mousa Mohammed A, Attia A, Farouk OE, Moustafa E. Effect of nursing guideline on nurses' knowledge and practices regarding chemotherapy for women with reproductive cancer. Egyptian J Health Care. 2021;12(3):956-67. [Link] [DOI:10.21608/ejhc.2021.193547]
17. Qalawa SA. The Relationship between oncology nurses' practice behaviors, knowledge and confidence regarding chemotherapy induced peripheral neuropathy. Port Said Sci J Nurs. 2017;4(1):1-17. [Link] [DOI:10.21608/pssjn.2017.33061]
18. Ahmed Sohil M, Afzal M, Yaqoob A. Association between nurses' knowledge and practice regarding chemotherapy induced peripheral neuropathy and its development in cancer patients. Pak J Health Sci. 2022;03(07):166-70. [Link] [DOI:10.54393/pjhs.v3i07.473]
19. Sadiq HS, Nasradeen Majeed B. Effectiveness of health educational program on pediatric nurses' knowledge regarding chemotherapy administration in Hiwa cancer hospital in Sulaimani city. J Sulaimani Med Coll. 2021;11(3):389-99. [Link] [DOI:10.17656/jsmc.10324]
20. Tofthagen CS, Visosky C, Hopgood R. Chemotherapy-induced peripheral neuropathy. Nurse Manage. 2013;17(2):138-44. [Link] [DOI:10.1188/13.CJON.138-144]
21. Ali Mohammed H, Kumait AS, Akbar Shakoor J, Nohman Othman P. Oncology nursing staff knowledge and practice behaviors toward chemotherapy impact on peripheral neuropathy: a study from North of Iraq. Bahrain Med Bull. 2021;43(4):715-19. [Link]
22. Binner M, Ross D, Browner I. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice. Home Oncol Nurs Forum. 2011;38(4):448-54. [Link] [DOI:10.1188/11.ONF.448-454]
23. Fan JX, Hu YC, Chen X, Li Y. Nursing dilemmas in chemotherapy-induced peripheral neuropathy: a qualitative study of a tertiary hospital in China. J Pain Res. 2023;16:2299-308. [Link] [DOI:10.2147/JPR.S409580]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |